Executive Summary
On January 23, 2026, a cluster of 42 8-K filings revealed widespread corporate distress among US small-cap companies, dominated by entries into material definitive agreements (Item 1.01 in ~80% of filings), often paired with unregistered equity sales (Item 3.02) and new financial obligations (Item 2.03), signaling acute liquidity pressures and desperate capital raises. A alarming spike in delistings (at least 5 biotech/pharma firms including KALA BIO, REVIVA, Aprea, Nexalin, and 60 Degrees) underscores sector-specific failures to meet listing standards, with bearish sentiment in high-materiality cases. Institutional investors face elevated portfolio risks in microcaps; prioritize derisking via shorts or avoids, monitoring for bankruptcy cascades amid correlated financing maneuvers.
Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from January 21, 2026.
Investment Signals(5)
- KALA BIO, Inc.β(BEARISH)β²
Notice of delisting or failure to satisfy listing standards
- β²
Delisting notification signals compliance failure and liquidity crisis
- Aprea Therapeutics, Inc.β(BEARISH)β²
Critical delisting risk with transfer of listing imminent
- Nexalin Technology, Inc.β(BEARISH)β²
High-risk delisting event amid ongoing distress
- NEXTNRG, INC.β(BEARISH)β²
Termination of material definitive agreement indicates strategic setbacks
Risk Flags(4)
- Biotech Delistings/Delisting RiskβΌ
Cluster of 5+ firms (KALA BIO, REVIVA, Aprea, Nexalin, 60 Degrees) failing Nasdaq standards, risking OTC downgrade and illiquidity
Combo of material agreement, new financial obligation, and unregistered equity sales flags balance sheet strain
Termination of agreement plus director/officer departures amid new financing suggests operational turmoil
Modifications to security holder rights alongside equity sales heightens dilution and control risks
Opportunities(3)
- SharonAI Holdings, Inc./New Agreementβ(ALPHA LONG)β
Fresh material definitive agreement post-termination could signal turnaround financing
- INNO HOLDINGS INC./Strategic Pactβ(DIP BUY)β
Entry into material agreement offers potential accretive growth if details prove positive
- LanzaTech Global, Inc./Restructuring Playβ(SHORT COVER)β
Multi-item filing with equity sales and bylaws changes may precede recovery in clean tech space
Sector Themes(3)
- Small-Cap Liquidity Squeezeβ
Over 30 filings with Item 1.01 (material agreements), Item 2.03 (debt obligations), and Item 3.02 (equity issuances) correlate to cash crunches, amplifying bankruptcy risks across microcaps
- Biotech Delisting Waveβ
5 high-materiality bearish delistings (KALA BIO et al.) indicate sector-wide compliance failures, tied to funding droughts; broader pharma distress imminent
- Governance & Instability Signalsβ
Recurring officer changes (Item 5.02), bylaws amendments (Item 5.03), and rights modifications (Item 3.03) suggest leadership churn amid financing distress
Watch List(4)
Fresh delisting notice with Reg FD disclosure; monitor bankruptcy filing risk
Multi-risk filing (debt, dilution, agreement); track for covenant breaches
Governance shifts and security rights changes; watch for shareholder actions
Unregistered equity sales paired with new agreement; potential dilution cascade
Filing Analyses(42)
23-01-2026
LanzaTech Global, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003163), reporting multiple items including Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Item 5.03), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial impacts disclosed in the provided summary. Sector is not specified.
23-01-2026
Axogen, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0000805928-26-000026, Size: 655 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core event, transaction value, financial impacts, or named entities disclosed in the provided summary. All quantitative data, scheduled events, and further context are NOT_DISCLOSED.
23-01-2026
NeoVolta Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001683168-26-000482), reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing for Items 1.01 and 2.02, with voluntary Item 7.01. No specific details on the agreement, transaction values, financial metrics, or impacts are disclosed in the provided information.
23-01-2026
Lendway, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006044), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, obligation, dollar values, counterparties, or other quantitative data disclosed in the provided summary. Sector is not specified.
23-01-2026
QT Imaging Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003206, Size: 903 KB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction values, parties involved, or financial impacts disclosed in the provided summary. Sector is not specified.
23-01-2026
NEXTNRG, INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003324, Size: 219 KB), reporting under Item 1.02 the termination of a material definitive agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, dollar values, or financial impacts provided in the summary. Sector not specified.
23-01-2026
Company filed Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006102), disclosing Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No details on the specific agreement, transaction terms, parties involved, financial impacts, or exhibits are provided in the excerpt. Analysis is severely limited by absence of filing content beyond item headers.
23-01-2026
Planet Labs PBC filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020587), reporting Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modifications to Rights of Security Holders), and Item 8.01 (Other Events). This is a multi-item filing with no specific transaction details, dollar values, share counts, or financial metrics disclosed. Core events involve equity securities sales and rights modifications, but all quantitative data is NOT_DISCLOSED.
23-01-2026
The company filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020910, Size: 2 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing as Item 1.01 triggers required disclosure within 4 business days. No specific details on the agreement, events, transaction value, parties, or financial impacts are disclosed in the provided filing summary.
23-01-2026
Company filed 8-K on 2026-01-23 (AccNo: 0001193125-26-020905) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 2.03 Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement. Item 9.01 discloses Financial Statements and Exhibits. No specific transaction details, values, parties, or terms provided.
23-01-2026
Company filed Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006208, Size: 2 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event, but specific details of the agreement, events, or exhibits are NOT_DISCLOSED. No quantitative data, named entities, or scheduled events are mentioned.
23-01-2026
The company filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006207, Size: 3 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item material event disclosure with no specific details provided on the agreement, events, transaction value, or financial impacts. Sector is not specified.
23-01-2026
VisionWave Holdings, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001731122-26-000106, Size: 644 KB) reporting a Material Event under Item 1.01 for Entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific details provided on the agreement, transaction terms, parties involved, or financial impacts. Sector is not specified.
23-01-2026
Ondas Holdings Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007197), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or quantitative impacts disclosed in the provided information. Sector not specified.
23-01-2026
SharonAI Holdings, Inc. filed Form 8-K on 2026-01-23 (AccNo: 0001829126-26-000505, Size: 765 KB) reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), departure/election/appointment of directors or certain officers including compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing covering material events. No specific transaction details, values, names, or financial metrics are disclosed.
23-01-2026
XCel Brands, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006234), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided summary. Sector is not specified.
23-01-2026
Jones Soda Co filed a Form 8-K on 2026-01-23 (AccNo: 0001493152-26-003378, size: 196 KB) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 1.02 Termination of a Material Definitive Agreement. This is a multi-item filing with no details provided on the agreements, parties, transaction values, or financial impacts. Sector not specified.
23-01-2026
KALA BIO, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001829126-26-000502) under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No additional details on the delisting reason, financial impacts, or transaction values are provided in the available information. Sector not specified.
23-01-2026
Two Hands Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001494413-26-000004, Size: 5 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing as a material event. No transaction details, dollar values, or other quantitative data disclosed.
23-01-2026
Blue Owl Technology Finance Corp. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003277, Size: 755 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, events, transaction values, or financial impacts are disclosed in the provided filing summary. Sector not specified.
23-01-2026
Abpro Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007215), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, named parties, or quantitative impacts disclosed. Sector not specified.
23-01-2026
NexPoint Real Estate Finance, Inc. filed an 8-K on 2026-01-23 (AccNo: 0001437749-26-001916, Size: 177 KB) reporting Item 1.01: Entry into a Material Definitive Agreement. No details on the agreement's parties, terms, value, or financial impact are provided in the summary. Sector not specified.
23-01-2026
Jaguar Health, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001193125-26-021064) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, share counts, or other numerical data disclosed in the provided summary. All core event details such as agreement terms, parties, or financial impacts are NOT_DISCLOSED.
23-01-2026
REVIVA PHARMACEUTICALS HOLDINGS, INC. filed an 8-K on 2026-01-23 (AccNo: 0001437749-26-001913, size 179 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, and under Item 8.01 Other Events. This indicates a delisting event from the US market, but no further details on reasons, financial impacts, or transaction values are disclosed.
23-01-2026
Company filed Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021081), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event, but specific details on the agreement, obligation, transaction value, parties, or exhibits are NOT_DISCLOSED in the provided information. No quantitative data, named entities, or scheduled events are mentioned.
23-01-2026
Jabil Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021086, Size: 582 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, transaction value, or financial impacts disclosed in the provided summary. Sector not specified.
23-01-2026
Six Flags Entertainment Corporation filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021051, Size: 150 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts disclosed in the provided information. Sector is not specified.
23-01-2026
GAXOS.AI INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007257, Size: 492 KB) reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided summary. Sector not specified.
23-01-2026
INNO HOLDINGS INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003411, Size: 462 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, financial impacts, or strategic rationale are disclosed in the provided information. Sector is not specified.
23-01-2026
Collab Z Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007244, Size: 601 KB), reporting multiple items: 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction values, parties involved, or financial impacts provided in the summary. Sector is not specified.
23-01-2026
Aprea Therapeutics, Inc. filed a Form 8-K on 2026-01-23 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No specific reasons, financial impacts, transaction values, or other details are disclosed in the provided summary. Filing Accession Number: 0001104659-26-006267, size: 191 KB.
23-01-2026
Bain Capital Specialty Finance, Inc. filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-021189), reporting entry into a Material Definitive Agreement under Item 1.01 and including Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts disclosed in the provided information. Sector not specified.
23-01-2026
NU RIDE INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003436, Size: 190 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 8.01 Other Events. No details on the agreement, transaction size, or events are disclosed in the provided summary. Sector is not specified.
23-01-2026
Form 8-K filed January 23, 2026 (AccNo: 0000929638-26-000243, Size: 3 MB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item Material Event filing from an unspecified company and sector. No details on the agreement, events, transaction value, or exhibits are disclosed.
23-01-2026
Pacific Oak Strategic Opportunity REIT, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001452936-26-000007, Size: 155 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. This is a multi-item filing with no specific transaction values, names, or financial details disclosed in the summary. Sector is not specified.
23-01-2026
Q/C TECHNOLOGIES, INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003440), reporting a multi-item disclosure under Items 1.01 (Entry into a Material Definitive Agreement), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, events, transaction values, financial metrics, or named entities are disclosed in the provided summary. All quantitative data, dollar values, share counts, and scheduled events are NOT_DISCLOSED.
23-01-2026
Modular Medical, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001213900-26-007296, Size: 1 MB) reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 5.07 (Submission of Matters to a Vote of Security Holders), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific event details, transaction values, or numerical data disclosed in the summary. Sector not specified.
23-01-2026
QHSLab, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003438), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided information. Sector is not specified.
23-01-2026
ProPhase Labs, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003456, Size: 893 KB), reporting a multi-item disclosure under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No details on the core transaction, parties, dollar value, share counts, or financial impacts are explicitly stated in the provided filing summary. This is a mandatory disclosure triggered by material events.
23-01-2026
Company filed Form 8-K on 2026-01-23 (AccNo: 0000921825-26-000003) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing classified as a Material Event. No specific details on the core event, transaction value, parties, financial impacts, or scheduled events are disclosed.
23-01-2026
Nexalin Technology, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001829126-26-000513, Size: 255 KB), reporting under Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This indicates a delisting event from the US market. No specific details on delisting reasons, financial impacts, transaction values, or other quantitative data are disclosed in the provided information.
23-01-2026
60 Degrees Pharmaceuticals, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007330, Size: 240 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, indicating delisting from the US market. Item 7.01 covers Regulation FD Disclosure. No quantitative data, financial impacts, or specific reasons for delisting are disclosed in the provided information.
Get daily alerts with 5 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 42 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC